Sustained Reduction of Serum Cholesterol in Low-Dose 6-Year Simvastatin Treatment With Minimum Side Effects in 51,321 Japanese Hypercholesterolemic Patients. Implication of the J-LIT Study, a Large Scale Nationwide Cohort Study.-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sustained Reduction of Serum Cholesterol in Low-Dose 6-Year Simvastatin Treatment With Minimum Side Effects in 51,321 Japanese Hypercholesterolemic Patients. Implication of the J-LIT Study, a Large Scale Nationwide Cohort Study.

Published:2003 Issue:4 Volume:67 Page:287-294
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Matsuzawa Yuji¹,Kita Toru²,Mabuchi Hiroshi³,Matsuzaki Masunori⁴,Nakaya Noriaki⁵,Oikawa Shinichi⁶,Saito Yasushi⁷,Sasaki Jun⁸,Shimamoto Kazuaki⁹,Itakura Hiroshige¹⁰,(Chairman of Central Committee); the J-LIT Study Group

Affiliation:

1. Osaka University Graduate School of Medicine

2. Kyoto University Graduate School of Medicine

3. Kanazawa University Graduate School of Medicine

4. Yamaguchi University Graduate School of Medicine

5. Fussa General Hospital

6. Nippon Medical School

7. Chiba University Graduate School of Medicine

8. International University Graduate School of Health and Welfare

9. Sapporo Medical University School of Medicine

10. Ibaraki Christian University

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/67/4/67_4_287/_pdf

Reference20 articles.

1. Design and baseline characteristics of a cohort study in Japanese patients with hypercholesterolemia: the Japan lipid intervention trial (J-LIT)

2. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study

3. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

4. Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia

5. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Large-scale next generation sequencing based analysis of SLCO1B1 pharmacogenetics variants in the Saudi population;Human Genomics;2024-03-25

2. High-Intensity Statin vs. Low-Density Lipoprotein Cholesterol Target for Patients Undergoing Percutaneous Coronary Intervention: Insights From a Territory-Wide Cohort Study in Hong Kong;Frontiers in Cardiovascular Medicine;2021-10-28

3. Familial hypercholesterolemia in Southeast and East Asia;American Journal of Preventive Cardiology;2021-06

4. Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects;Expert Opinion on Drug Metabolism & Toxicology;2020-08-11

5. Impact of Plasma Exposure of Statins and Their Metabolites With Major Adverse Cardiovascular Events in Chinese Patients With Coronary Artery Disease;Frontiers in Pharmacology;2020-05-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3